Wright Jason D, Chen Ling, Hou June Y, Burke William M, Tergas Ana I, Ananth Cande V, Neugut Alfred I, Hershman Dawn L
Departments of Obstetrics and Gynecology and Medicine and the Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons, the Department of Epidemiology, Joseph L. Mailman School of Public Health, Columbia University, and New York Presbyterian Hospital, New York, New York.
Obstet Gynecol. 2017 Sep;130(3):545-553. doi: 10.1097/AOG.0000000000002164.
To assess whether strict adherence to quality metrics by hospitals could explain the association between hospital volume and survival for ovarian cancer.
We used the National Cancer Database to perform a retrospective cohort study of women with ovarian cancer from 2004 to 2013. Hospitals were stratified by annual case volume into quintiles (2 or less, 2.01-5, 5.01-9, 9.01-19.9, 20 cases or greater) and by adherence to ovarian cancer quality metrics into quartiles. Hospital-level adjusted 2- and 5-year survival rates were compared based on volume and adherence to the quality metrics.
A total of 100,725 patients at 1,268 hospitals were identified. Higher volume hospitals were more likely to adhere to the quality metrics. Both 2- and 5-year survival increased with hospital volume and with adherence to the measured quality metrics. For example, 2-year survival increased from 64.4% (95% CI 62.5-66.4%) at low-volume to 77.4% (95% CI 77.0-77.8%) at high-volume centers and from 66.5% (95% CI 65.5-67.5%) at low-quality to 77.3% (95% CI 76.8-77.7%) at high-quality hospitals (P<.001 for both). For each hospital volume category, survival increased with increasing adherence to the quality metrics. For example, in the lowest volume hospitals (two or less cases annually), adjusted 2-year survival was 61.4% (95% CI 58.4-64.5%) at hospitals with the lowest adherence to quality metrics and rose to 65.8% (95% CI 61.2-70.8%) at the hospitals with highest adherence to the quality metrics (P<.001). However, lower volume hospitals with higher quality scores still had survival that was lower than higher volume hospitals.
Although both hospital volume and adherence to quality metrics are associated with survival for ovarian cancer, low-volume hospitals that provide high-quality care still have survival rates that are lower than high-volume centers.
评估医院严格遵守质量指标是否能解释医院病例数量与卵巢癌患者生存率之间的关联。
我们利用国家癌症数据库对2004年至2013年期间的卵巢癌女性患者进行了一项回顾性队列研究。医院按年病例数量分为五等份(2例及以下、2.01 - 5例、5.01 - 9例、9.01 - 19.9例、20例及以上),并按对卵巢癌质量指标的遵守情况分为四等份。根据病例数量和对质量指标的遵守情况比较医院层面调整后的2年和5年生存率。
共识别出1268家医院的100725例患者。病例数量较多的医院更有可能遵守质量指标。2年和5年生存率均随医院病例数量增加以及对所测质量指标的遵守情况而提高。例如,2年生存率从低病例数量中心的64.4%(95%可信区间62.5 - 66.4%)提高至高病例数量中心的77.4%(95%可信区间77.0 - 77.8%),从低质量医院的66.5%(95%可信区间65.5 - 67.5%)提高至高质量医院的77.3%(95%可信区间76.8 - 77.7%)(两者P均<0.001)。对于每个医院病例数量类别,生存率随对质量指标遵守情况的增加而提高。例如,在病例数量最少的医院(每年2例及以下),对质量指标遵守程度最低的医院调整后2年生存率为61.4%(95%可信区间58.4 - 64.5%),而对质量指标遵守程度最高的医院则升至65.8%(95%可信区间61.2 - 70.8%)(P<0.001)。然而,质量得分较高的低病例数量医院的生存率仍低于高病例数量医院。
虽然医院病例数量和对质量指标的遵守情况均与卵巢癌患者生存率相关,但提供高质量护理的低病例数量医院的生存率仍低于高病例数量中心。